Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
Clinical trial NCT03286114 · TERMINATED
Trial details
- NCT number
- NCT03286114
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2020-10-22
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.